VCIM
CABA icon

Velan Capital Investment Management’s Cabaletta Bio CABA Stock Holding History

Velan Capital Investment Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-150,000
Closed -$2.28M – 22
2023
Q3 		$2.28M Sell
150,000
-100,000
-40% -$1.37M 1.84% 15
2023
Q2 		$3.23M Hold
250,000
– – 3% 12
2023
Q1 		$2.07M Buy
+250,000
New +$2.34M 1.76% 15

Other funds holding CABA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Velan Capital Investment Management's CABA Position: Q4 2023 in Review

Velan Capital Investment Management sold out of Cabaletta Bio (CABA) in Q4 2023, closing a stake of 150,000 shares — an estimated $2.28M sold.

Velan Capital Investment Management first reported a position in CABA in Q1 2023 and held it in 3 quarters. The position peaked at $3.23M in Q2 2023. 128 funds tracked by Wall St. Rank hold CABA as of Q4 2023.

  • Velan Capital Investment Management reported no remaining Cabaletta Bio position as of Q4 2023 after selling out during the quarter.
  • Velan Capital Investment Management sold 150,000 Cabaletta Bio shares in Q4 2023, an estimated $2.28M.
  • Velan Capital Investment Management first reported a position in Cabaletta Bio in Q1 2023 and held it in 3 quarters.
  • Velan Capital Investment Management's Cabaletta Bio position peaked at $3.23M in Q2 2023.
  • 128 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2023.

Based on Velan Capital Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.